Protocol GS-US-259-1837, ???A Phase 3, Randomized, Doubl

Project: Research project

Project Details

Description

Protocol GS-US-259-1837, ???A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Ranolazine in Male Subjects with Duchenne Muscular Dystrophy (DMD) and Declining Upper Extremity Function
StatusFinished
Effective start/end date10/2/1511/13/15

Funding

  • Gilead Sciences, Inc.